The company's Owkin Socrates platform applies transfer and federated learning to clinical research.

Icon has hired a retired colonel who is moving into the biotech sphere as new president of its subsidiary ClinicalRM.

The $58 million financing round represents biopharma industry's growing interest in genomics data.

JSR Life Sciences’ parent company will pay NT$12 billion ($400 million) for Crown Bioscience International, boosting its global footprint and CRO offerings.

The product of a merger of Pluriomics and Axiogenesis, iPSC company Ncardia has signed licensing deals with Roche and Evotec.

X-Chem will screen its DNA-encoded libraries to discover novel antivirals for Gilead.

Enyo Pharma has successfully identified potential targets of its preclinical molecule series EYP002 with Charles River's technology.

HitGen has formed a drug discovery research collaboration with Boehringer Ingelheim to identify novel small-molecule leads.